Guggenheim Capital LLC Reata Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $266,871 - $373,071	-2,113 Closed	0 $0
Q1 2020 Jun 02, 2020	SELL	$124.16 - $247.74 $16,885 - $33,692	-136 Reduced 6.05%	2,113 $305,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $167,707 - $490,102	2,249 New	2,249 $460,000
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $164,895 - $221,565	-2,314 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $179,844 - $218,325	2,314 New	2,314 $218,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.